- Poster presentation
- Open Access
Digital cervicography and cold coagulation for cervical cancer screening in Nigeria
Infectious Agents and Cancervolume 7, Article number: P14 (2012)
Cervical cancer (CC) is most common cancer among women in Africa and in women living with HIV [1, 2]. Its prevalence has remained stable or increasing with introduction of HAART suggesting complex interactions with HIV [3, 4]. Current screening programs can substantially reduce all-cause mortality of CC but implementation in LMIC is hobbled by poor infrastructure, cost and lack of personnel. Nurse provider led, minimal visit, screen and treat programs offer an opportunity to reduce CC morbidity and mortality in LMIC . In this study we evaluate the implementation of cervical cancer screen and treat programs at 2 HIV treatment and prevention sites in Nigeria.
Material and methods
CC screening programs using nurse providers, VIA, off the shelf camera for digital cervicography, treatment of eligible lesions by cold coagulation and referral as required was implemented at 2 PEPFAR supported sites in Abuja, Central Nigeria. QA was provided by Gynecologist and based on weekly review of digital cervicographs and client recall as required.
From July 2010 to July 2011, 2002 HIV+ women had been screened for CC at the 2 sites, but only data on 925 is reported in this abstract. Mean (SD) age was 35.2 (7.0) years; mean (sd) age at sexual debut was 19.0 (3.9) years; range, mean, sd of pregnancies was 0 – 16, 3.4, 2.5; range, mean, sd of pregnancies was 0 – 12, 1.6, 1.8; range, mean, sd of most recent cd4 count before screening was 11 – 1197, 466.7, 239.0; 6.8% were VIA positive; 0.2% had invasive CC and 0.2% were uncertain. Concordance between the clinical review and nursing diagnosis was 65% at the beginning of the program but reached 100% after 3 months.
This study showed nurse provider led CC screening and treatment program is a viable public health intervention among PLWHIV in Nigeria.
Boyle P, Levin B: World Cancer Report 2008. 2008, Geneva: International Agency for Research on Cancer
Clarke B, Chetty R: Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol. 2002, 55: 19-24. 10.1136/mp.55.1.19.
Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA: Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006, 118: 985-990. 10.1002/ijc.21443.
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet. 2007, 370: 890-907. 10.1016/S0140-6736(07)61416-0.
Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP: Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011, 8: e1001032-10.1371/journal.pmed.1001032.
This study is supported by the IHV-UM Capacity Development for Research into AIDS Associated Malignancies (NIH/NCI D43CA153792-01 PI, Adebamowo) and IHV-UM AIDS International Training and Research Program (NIH/FIC D43TW001041-11 PI, Blattner).